BioStabilization Systems (BoSS)
Health and Human Services, Department of · NATIONAL INSTITUTES OF HEALTH
This notice is not accepting responses (deadline was Mar 25, 2026, 8:00 PM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Mar 25, 2026, 8:00 PM EDT
- Posted
- Dec 1, 2025
- Solicitation
- ARPA-H-SOL-26-136
- Set-aside
- None listed
- Place of performance
- Washington, DC, USA
- Contracting office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) · Washington · DC
- Source
- SAM.gov · updated May 14, 2026
Description
The BioStabilization Systems (BoSS) program aims to transform how live cell-based therapies are stabilized, manufactured, and distributed. At its core, BoSS addresses a foundational bottleneck in the delivery of advanced cell and gene therapies (CGTs): the critical dependence on ultra-cold conditions (-80 to -196?C) for storage and transport. BoSS will yield a bioprocessing system that enables scalable production of thermally stable cells, paving the way for a new era of efficient and resilient manufacturing and distribution of biologics without any need for cold storage. BoSS-developed technologies will also accelerate many other avenues in biotechnology that directly impact healthcare, including bio-surveillance, regenerative medicine, large-scale genetic testing, blood product supply, and wound repair, in addition to improving access to a wide range of existing biotherapeutics. Solution Summaries are required: For consideration as a Performer: Solution Summary due date: February 19th, 2026 5:00 PM ET For consideration as an IV&V partner: Solution Summary due date: April 17th, 2026 5:00 PM ET Interested parties are invited to review the attached BoSS Innovative Solutions Opening (ISO) ARPA-H -SOL-26-136. Submissions must be made to: Solution Summary Submission Site: https://solutions.arpa-h.gov/Submit-Solution/ Please ensure to follow this opportunity for any updates. For more information on the BoSS program visit: https://arpa-h.gov/explore-funding/programs/boss
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$2.05M
Middle of the pack for similar past awards
Most similar awards fall between $599,884 and $3.65M
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1MAPP BIOPHARMACEUTICAL, INC.1 award$56.70M
- 2THERADEX SYSTEMS, INC.1 award$34.79M
- 3TECHNICAL RESOURCES INTERNATIONAL, INC.2 awards$34.26M
- 4BIOAEGIS THERAPEUTICS INC1 award$20.00M
- 5SYNEDGEN, INC.1 award$18.83M
- 6PARTNER THERAPEUTICS, INC.1 award$12.99M
- 7TRITON SYSTEMS, INC.2 awards$7.59M
- 8OPTOSURGICAL, LLC2 awards$7.00M
Recent examples
A few of the newest similar awards in our index.
- UNIVERSITY OF ROCHESTERSep 30, 2025Department of Health and Human Services$4.26MSource
- BIOAEGIS THERAPEUTICS INCSep 30, 2025Department of Health and Human Services$20.00MSource
- ECS FEDERAL, LLCSep 29, 2025Department of Veterans Affairs$848,402Source
- SYNEDGEN, INC.Sep 26, 2025Department of Health and Human Services$18.83MSource
- GEN1E LIFESCIENCES INC.Sep 19, 2025Department of Health and Human Services$749,000Source
- OPTOSURGICAL, LLCSep 12, 2025Department of Health and Human Services$3.50MSource
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 372c6d71933a4d76a899cff981a9df84.